Top 5 Stock Picks of Paul Marshall and Ian Wace’s Marshall Wace LLP

4. Teleflex Incorporated (NYSE:TFX)

Paul Marshall and Ian Wace’s Marshall Wace LLP’s Stake Value: $259,409,000

Percentage of Paul Marshall and Ian Wace’s Marshall Wace LLP’s 13F Portfolio: 1.07%

Number of Hedge Funds: 26

Teleflex Incorporated (NYSE:TFX) is a provider of specialized medical devices for the treatment of patients in critical care. The company operates in over 40 countries and employs more than 12,000 people.

On December 9, Shagun Singh at RBC Capital initiated coverage on Teleflex Incorporated (NYSE:TFX) with a $415 price target and an Outperform rating.

Teleflex Incorporated (NYSE:TFX) was mentioned in the Q1 2021 investor letter of ClearBridge Investments. Here’s what the investment management firm said:

“Teleflex is a diversified medical device company with leading market share in several low-cost consumable niche categories, creating high-margin recurring revenue streams with steady growth and pricing. Its unique UroLift product has the potential to accelerate growth of the company with its strong positioning as the only minimally invasive product to treat BPH in the prostate gland with no side effects, a treatment area with a large total addressable market.”